Tachykinin NK3 receptor contribution to systemic release of vasopressin and oxytocin in response to osmotic and hypotensive challenge

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 293, Issue 2, 2007, Pages

  Haley, Gwendolen E ^a   Flynn, Francis W ^a  

^a UNIVERSITY OF WYOMING   (United States)

Author keywords

Hydralazine; Hyperosmolarity; Hypotension

Indexed keywords

HYDRALAZINE; N (ALPHA ETHYLBENZYL) 3 METHYL 2 PHENYL 4 QUINOLINECARBOXAMIDE; NEUROKININ 3 RECEPTOR; OXYTOCIN; SODIUM CHLORIDE; TACHYKININ RECEPTOR; TACHYKININ RECEPTOR ANTAGONIST; VASOPRESSIN;

ANALYTIC METHOD; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BOLUS INJECTION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HORMONE RELEASE; HYPEROSMOLARITY; HYPOTENSION; INDWELLING CATHETER; MALE; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; HYDRALAZINE; HYPOTENSION; HYPOTHALAMUS; INFUSIONS, INTRAVENOUS; INJECTIONS, INTRAVENTRICULAR; MALE; OSMOTIC PRESSURE; OXYTOCIN; QUINOLINES; RATS; RECEPTORS, NEUROKININ-3; SODIUM CHLORIDE; VASODILATOR AGENTS; VASOPRESSINS; WATER-ELECTROLYTE BALANCE;

EID: 34547647248     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00196.2007     Document Type: Article

References (45)

1. Akins VF, Bealer SL. Central nervous system histamine regulates peripheral sympathetic activity. Am J Physiol Heart Circ Physiol 260: H218-H224, 1991.
2. Akins VF, Bealer SL. Hypothalamic histamine release, neuroendocrine and cardiovascular responses during tuberomammillary nucleus stimulation in the conscious rat. Neuroendocrinology 57: 849-855, 1993.
3. Allen BJ, Li J, Menning PM, Rogers SD, Ghilardi J, Mantyh PW, Simone DA. Primary afferent fibers that contribute to increased substance P receptor internalization in the spinal cord after injury. J Neurophysiol 81: 1379-1390, 1999.
4. Aradachi H, Honda K, Negoro H, Kubota T. Median preoptic neurones projecting to the supraoptic nucleus are sensitive to haemodynamic changes as well as to rise in plasma osmolality in rats. J Neuroendocrinol 8: 35-43, 1996.
5. Bealer S. Central control of cardiac baroreflex responses during peripheral hyperosmolality. Am J Physiol Regul Integr Comp Physiol 278: R1157-R1163, 2000.
6. Bealer SL, Flynn FW. Central neurokinin 3 receptors increase systemic oxytocin release: interaction with norepinephrine. Exp Neurol 184: 1027-1033, 2003.
7. Bourque CW, Oliet SH. Osmoreceptors in the central nervous system. Annu Rev Physiol 59: 601-619, 1997.
8. Bourque CW, Oliet SH, Richard D. Osmoreceptors osmoreception, osmoregulation. Front Neuroendocrinol 15: 231-274, 1994.
9. Buggy J, Johnson AK. Angiotensin-induced thirst: effects of third ventricle obstruction and periventricular ablation. Brain Res 149: 117-128, 1978.
10. Buller KM, Smith DW, Day TA. Differential recruitment of hypothalamic neuroendocrine and ventrolateral medulla catecholamine cells by non-hypotensive and hypotensive hemorrhages. Brain Res 834: 42-54, 1999.
11. Camacho A, Phillips MI. Horseradish peroxidase study in rat of the neural connections of the organum vasculosum of the lamina terminalis. Neurosci Lett 25: 201-204, 1981.
12. Crofton JT, Share L. Osmotic control of vasopressin in male and female rats. Am J Physiol Regul Integr Comp Physiol 257: R738-R743, 1989.
13. Day TA, Ferguson AV, Renaud LP. Facilitatory influence of noradrenergic afferents on the excitability of rat paraventricular nucleus neurosecretory cells. J Physiol 355: 237-249, 1984.
14. Decavel C, Geffard M, Calas A. Comparative study of dopamine- and noradrenaline-immunoreactive terminals in the paraventricular and supraoptic nuclei of the rat. Neurosci Lett 77: 149-154, 1987.
15. Ding YQ, Lu BZ, Guan ZL, Wang DS, Xu JQ, Li J. Neurokinin B receptor (NK3)-containing neurons in the paraventricular and supraoptic nuclei of the rat hypothalamus synthesize vasopressin and express Fos following intravenous injection of hypertonic saline. Neuroscience 91: 1077-1085, 1999.
16. Ding YQ, Shigemoto R, Takada M, Ohishi H, Nakanishi S, Mizuno N. Localization of the neuromedin K receptor (NK3) in the central nervous system of the rat. J Comp Neurol 364: 290-310, 1996.
17. Dinh TT, Flynn FW, Ritter S. Hypotensive hypovolemia and hypoglycemia activate different hindbrain catecholamine neurons with projections to the hypothalamus. Am J Physiol Regul Integr Comp Physiol 291: R870-R879, 2006.
18. Eguchi T, Takano Y, Hatae T, Saito R, Nakayama Y, Shigeyoshi Y, Okamura H, Krause JE, Kamiya H. Antidiuretic action of tachykinin NK-3 receptor in the rat paraventricular nucleus. Brain Res 743: 49-55, 1996.
19. Fabian M, Forsling ML, Jones JJ, Lee J. The release, clearance, and plasma protein binding of oxytocin in the anaesthetized rat. J Endocrinol 43: 175-189, 1969.
20. Flynn FW, Haley GE, Adams DJ, Bealer SL. Magnocellular oxytocin neurons express the tackykinin NK3 receptor. In: Society for Neuroscience Abstract Volume. Atlanta, GA: Society for Neuroscience, 2006.
21. Gardiner TW, Verbalis JG, Stricker EM. Impaired secretion of vasopressin and oxytocin in rats after lesions of nucleus medianus. Am J Physiol Regul Integr Comp Physiol 249: R681-R688, 1985.
22. Haley GE, Flynn FW. Agonist and hypertonic saline-induced trafficking of the NK3-receptors on vasopressin neurons within the paraventricular nucleus of the hypothalamus. Am J Physiol Regul Integr Comp Physiol 290: R1242-R1250, 2006.
23. Honore P, Menning PM, Rogers SD, Nichols ML, Basbaum AI, Besson JM, Mantyh PW. Spinal substance P receptor expression and internalization in acute, short-term, and long-term inflammatory pain states. J Neurosci 19: 7670-7678, 1999.
24. Howe HE, Somponpun SJ, Sladek CD. Role of neurokinin 3 receptors in supraoptic vasopressin and oxytocin neurons. J Neurosci 24: 10103-10110, 2004.
25. Imura H, Nakao K, Itoh H. The natriuretic peptide system in the brain: implications in the central control of cardiovascular and neuroendocrine functions. Front Neuroendocrinol 13: 217-249, 1992.
26. Jhamandas JH, Lind RW, Renaud LP. Angiotensin II may mediate excitatory neurotransmission from the subfornical organ to the hypothalamic supraoptic nucleus: an anatomical and electrophysiological study in the rat. Brain Res 487: 52-61, 1989.
27. Khanna S, Sibbald JR, Smith DW, Day TA. Initiation of rat vasopressin cell responses to simulated hypotensive hemorrhage. Am J Physiol Regul Integr Comp Physiol 267: R1142-R1149, 1994.
28. Kiss A, Mikkelsen JD. Oxytocin-anatomy and functional assignments: a minireview. Endocr Regul 39: 97-105, 2005.
29. Landgraf R, Neumann I, Schwarzberg H. Central and peripheral release of vasopressin and oxytocin in the conscious rat after osmotic stimulation. Brain Res 457: 219-225, 1988.
30. Lavielle S, Chassaing G, Ploux O, Loeuillet D, Besseyre J, Julien S, Marquet A, Convert O, Beaujouan JC, Torrens Y, Bergstrom L, Saffroy M, Glowinski J. Analysis of tachykinin binding site interactions using constrained analogues of tachykinins. Biochem Pharmacol 37: 41-49, 1988.
31. Mantyh PW, Allen CJ, Ghilardi J, Rogers SD, Mantyh CR, Liu H, Basbaum AI, Vigna SR, Maggio JE. Rapid endocytosis of a G protein-coupled receptor: substance P-evoked internalization of its receptor in the rat striatum in vivo. Proc Natl Acad Sci USA 92: 2622-2626, 1995.
32. Massi M, Saija A, Polidori C, Perfumi M, Gentili L, Costa G, de Caro G. The hypothalamic paraventricular nucleus is a site of action for the central effect of tachykinins on plasma vasopressin. Brain Res Bull 26: 149-154, 1991.
33. Meister B, Cortes R, Villar MJ, Schalling M, Hokfelt T. Peptides and transmitter enzymes in hypothalamic magnocellular neurons after administration of hyperosmotic stimuli: comparison between messenger RNA and peptide/protein levels. Cell Tissue Res 260: 279-297, 1990.
34. Mileusnic D, Lee JM, Magnuson DJ, Hejna MJ, Krause JE, Lorens JB, Lorens SA. Neurokinin-3 receptor distribution in rat and human brain: an immunohistochemical study. Neuroscience 89: 1269-1290, 1999.
35. Mori M, Tsushima H, Matsuda T. Substance P injected into the hypothalamic supraoptic nucleus causes antidiuresis through the release of arginine-vasopressin in water-loaded and ethanol-anesthetized rats. Jpn J Pharmacol 62: 49-53, 1993.
36. Oldfield BJ, Badoer E, Hards DK, McKinley MJ. Fos production in retrogradely labelled neurons of the lamina terminalis following intravenous infusion of either hypertonic saline or angiotensin II. Neuroscience 60: 255-262, 1994.
37. Oliveira GR, Franci CR, Rodovalho GV, Franci JA, Morris M, Rocha MJ. Alterations in the central vasopressin and oxytocin axis after lesion of a brain osmotic sensory region. Brain Res Bull 63: 515-520, 2004.
38. Onaka T, Luckman SM, Antonijevic I, Palmer JR, Leng G. Involvement of the noradrenergic afferents from the nucleus tractus solitarii to the supraoptic nucleus in oxytocin release after peripheral cholesystekinin octapeptide in the rat. Neuroscience 66: 403-412, 1995.
39. Polidori C, Saija A, Perfumi M, Costa G, Massi M. Vasopressin release induced by intracranial injection of tachykinins is due to activation of central neurokinin-3 receptors. Neurosci Lett 103: 320-325, 1989.
40. Raby WN, Renaud LP. Dorsomedial medulla stimulation activates rat supraoptic oxytocin and vasopressin neurones through different pathways. J Physiol 417: 279-294, 1989.
41. Richard D, Bourque CW. Synaptic control of rat supraoptic neurones during osmotic stimulation of the organum vasculosm lamina terminalis in vitro. J Physiol 489: 567-577, 1995.
42. Sadowski S, Huang RR, Fong TM, Marko O, Cascieri MA. Characterization of the binding of [125-I-Iodo-histidyl, Methyl-Phe7] neurokinin B to the neurokinin-3 receptor. Neuropeptides 24: 317-319, 1993.
43. Sawchenko PE, Swanson LW. The organization of noradrenergic pathways from the brainstem to the paraventricular and supraoptic nuclei in the rat. Brain Res 257: 275-325, 1982.
44. Schiltz JC, Hoffman GE, Stricker EM, Sved AF. Decreases in arterial pressure activate oxytocin neurons in conscious rats. Am J Physiol Regul Integr Comp Physiol 273: R1474-R1483, 1997.
45. Shughrue PJ, Lane MV, Merchenthaler I. In situ hybridization analysis of the distribution of neurokinin-3 mRNA in the rat central nervous system. J Comp Neurol 372: 395-414, 1996.